These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 21348302

  • 1. [Synergistic effect and its possible mechanisms of lidamycin in combination with TRAIL in NSCLC].
    Yang J, Chen SZ.
    Yao Xue Xue Bao; 2010 Oct; 45(10):1247-53. PubMed ID: 21348302
    [Abstract] [Full Text] [Related]

  • 2. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells.
    Sun SY, Yue P, Hong WK, Lotan R.
    Cancer Res; 2000 Dec 15; 60(24):7149-55. PubMed ID: 11156424
    [Abstract] [Full Text] [Related]

  • 3. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5.
    Choi SY, Kim MJ, Chung HY, Lee SJ, Jang YJ.
    Oncol Rep; 2007 Jan 15; 17(1):175-84. PubMed ID: 17143496
    [Abstract] [Full Text] [Related]

  • 4. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
    Liu X, Yue P, Chen S, Hu L, Lonial S, Khuri FR, Sun SY.
    Cancer Res; 2007 May 15; 67(10):4981-8. PubMed ID: 17510429
    [Abstract] [Full Text] [Related]

  • 5. Chloroquine potentiates the anti-cancer effect of lidamycin on non-small cell lung cancer cells in vitro.
    Liu F, Shang Y, Chen SZ.
    Acta Pharmacol Sin; 2014 May 15; 35(5):645-52. PubMed ID: 24727941
    [Abstract] [Full Text] [Related]

  • 6. [Synergistic apoptotic effect of the combination of diosgenin and TRAIL on non-small-cell lung cancer cell line A549 evaluated with the Chou-Talalay method].
    He Y, Wang JS, Zhang P, Zhang WJ, Huang QL, Hua ZC.
    Yao Xue Xue Bao; 2013 Jan 15; 48(1):45-51. PubMed ID: 23600140
    [Abstract] [Full Text] [Related]

  • 7. Enediyne lidamycin enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib, in epidermoid carcinoma A431 cells and lung carcinoma H460 cells.
    Liu H, Li L, Li XQ, Liu XJ, Zhen YS.
    Anticancer Drugs; 2009 Jan 15; 20(1):41-9. PubMed ID: 19342999
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Death receptor 5 and cellular FLICE-inhibitory protein regulate pemetrexed-induced apoptosis in human lung cancer cells.
    Su L, Liu G, Hao X, Zhong N, Zhong D, Liu X, Singhal S.
    Eur J Cancer; 2011 Nov 15; 47(16):2471-8. PubMed ID: 21726997
    [Abstract] [Full Text] [Related]

  • 10. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
    Chen S, Liu X, Yue P, Schönthal AH, Khuri FR, Sun SY.
    Mol Pharmacol; 2007 Nov 15; 72(5):1269-79. PubMed ID: 17684158
    [Abstract] [Full Text] [Related]

  • 11. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
    Cuello M, Ettenberg SA, Nau MM, Lipkowitz S.
    Gynecol Oncol; 2001 Jun 15; 81(3):380-90. PubMed ID: 11371126
    [Abstract] [Full Text] [Related]

  • 12. Caspase-dependent molecular mechanisms of anti-human DR5 monoclonal antibody mDRA-6 inducing apoptosis of human leukemia Jurkat cells.
    Du YW, Liu GC, Wang J, Zhao YP, Li SL, Chen JG, Jiang Q, Cai J, Ma YF.
    Ai Zheng; 2009 Feb 15; 28(2):112-6. PubMed ID: 19550122
    [Abstract] [Full Text] [Related]

  • 13. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.
    Liu X, Yue P, Zhou Z, Khuri FR, Sun SY.
    J Natl Cancer Inst; 2004 Dec 01; 96(23):1769-80. PubMed ID: 15572759
    [Abstract] [Full Text] [Related]

  • 14. Antitumor activity of a novel recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand.
    Fang F, Wang AP, Yang SF.
    Acta Pharmacol Sin; 2005 Nov 01; 26(11):1373-81. PubMed ID: 16225761
    [Abstract] [Full Text] [Related]

  • 15. Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460.
    Huisman C, Ferreira CG, Bröker LE, Rodriguez JA, Smit EF, Postmus PE, Kruyt FA, Giaccone G.
    Clin Cancer Res; 2002 Feb 01; 8(2):596-606. PubMed ID: 11839682
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells.
    Sun SY, Yue P, Zhou JY, Wang Y, Choi Kim HR, Lotan R, Wu GS.
    Biochem Biophys Res Commun; 2001 Jan 26; 280(3):788-97. PubMed ID: 11162590
    [Abstract] [Full Text] [Related]

  • 17. [Lidamycin inhibits the proliferation of HERG K+ channel highly expressing cancer cells and shows synergy with anticancer drugs].
    Shang BY, Shang Y, Zhen YS, Chen SZ.
    Yao Xue Xue Bao; 2011 Nov 26; 46(11):1321-5. PubMed ID: 22260022
    [Abstract] [Full Text] [Related]

  • 18. Role of elevated pressure in TRAIL-induced apoptosis in human lung carcinoma cells.
    Oh S, Kwon D, Lee HJ, Kim J, Lee E.
    Apoptosis; 2010 Dec 26; 15(12):1517-28. PubMed ID: 20623193
    [Abstract] [Full Text] [Related]

  • 19. Galbanic acid potentiates TRAIL induced apoptosis in resistant non-small cell lung cancer cells via inhibition of MDR1 and activation of caspases and DR5.
    Kim YH, Shin EA, Jung JH, Park JE, Koo J, Koo JI, Shim BS, Kim SH.
    Eur J Pharmacol; 2019 Mar 15; 847():91-96. PubMed ID: 30689998
    [Abstract] [Full Text] [Related]

  • 20. [Cisplatin enhances TRAIL-induced apoptosis in gastric cancer cells through clustering death receptor 4 into lipid rafts].
    Xu L, Qu XJ, Liu YP, Liu J, Zhang Y, Hou KZ, Jiang YH.
    Zhonghua Zhong Liu Za Zhi; 2011 Jul 15; 33(7):484-8. PubMed ID: 22093622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.